2019
Pancreatic Intraductal Papillary Mucinous Neoplasm With Elevated Pre-Operative Cystic Carcinoembryonic Antigen Level: A Histopathologic Correlation
Beech C, Freedman-Weiss M, Salem R, Jain D, Zhang X. Pancreatic Intraductal Papillary Mucinous Neoplasm With Elevated Pre-Operative Cystic Carcinoembryonic Antigen Level: A Histopathologic Correlation. Gastroenterology Research 2019, 12: 185-190. PMID: 31523327, PMCID: PMC6731045, DOI: 10.14740/gr1201.Peer-Reviewed Original ResearchCarcinoembryonic antigen levelCEA levelsInvasive carcinomaAntigen levelsCEA stainingIntraductal papillary mucinous neoplasm subtypesPancreatic intraductal papillary mucinous neoplasmsIntraductal papillary mucinous neoplasmPresence of dysplasiaPapillary mucinous neoplasmGrade of dysplasiaRisk of malignancySize of lesionsDuct involvementPathologic variablesCystic lesionsIPMN casesMucinous neoplasmsMucinous secretionHistopathologic correlationNeoplasm subtypesCarcinomaGlycoprotein expressionSignificant correlationDysplasia
2011
Neoadjuvant chemoradiation followed by interstitial prostate brachytherapy for synchronous prostate and rectal cancer
Qiu H, Herman JM, Ahuja N, DeWeese TL, Song DY. Neoadjuvant chemoradiation followed by interstitial prostate brachytherapy for synchronous prostate and rectal cancer. Practical Radiation Oncology 2011, 2: e77-e84. PMID: 24674189, DOI: 10.1016/j.prro.2011.11.001.Peer-Reviewed Original ResearchSynchronous prostateRectal cancerAdjuvant chemotherapyPelvic chemoradiationProstate brachytherapyGrade 3 gastrointestinal toxicityHigh-risk prostate cancerCarcinoembryonic antigen levelLow anterior resectionTreatment-related toxicityEvidence of relapseInterstitial prostate brachytherapyProstate interstitial brachytherapyInternal Review BoardAnterior resectionBony metastasesGastrointestinal toxicityLoop ileostomyNeoadjuvant chemoradiationRetrospective reviewAntigen levelsMonths postdiagnosisPhysical examinationProstate cancerInterstitial brachytherapy
2005
Yttrium 90 Resin Microspheres for the Treatment of Unresectable Colorectal Hepatic Metastases after Failure of Multiple Chemotherapy Regimens: Preliminary Results
Murthy R, Xiong H, Nunez R, Cohen AC, Barron B, Szklaruk J, Madoff DC, Gupta S, Wallace MJ, Ahrar K, Hicks ME. Yttrium 90 Resin Microspheres for the Treatment of Unresectable Colorectal Hepatic Metastases after Failure of Multiple Chemotherapy Regimens: Preliminary Results. Journal Of Vascular And Interventional Radiology 2005, 16: 937-945. PMID: 16002501, DOI: 10.1097/01.rvi.0000161142.12822.66.Peer-Reviewed Original ResearchConceptsUnresectable colorectal hepatic metastasesColorectal hepatic metastasesHepatic metastasesSIR-SpheresMultiple chemotherapySingle infusionPrescribed doseYttrium-90 resin microspheresEmbolic arterial occlusionHepatic metastatic diseaseMultiple chemotherapy regimensLiver-directed therapiesCarcinoembryonic antigen levelYttrium-90 microspheresCompletion of treatmentMedian survival timeHepatic tumor volumeBilobar diseaseIntrahepatic progressionRadiologic responseUnilobar diseaseAdvanced diseaseChemotherapy regimenChemotherapy regimensIntraarterial chemotherapy
2000
Intra‐abdominal fibrosis after systemic and intraperitoneal therapy containing fluoropyrimidines
Fata F, Ron I, Maluf F, Klimstra D, Kemeny N. Intra‐abdominal fibrosis after systemic and intraperitoneal therapy containing fluoropyrimidines. Cancer 2000, 88: 2447-2451. PMID: 10861419, DOI: 10.1002/1097-0142(20000601)88:11<2447::aid-cncr4>3.0.co;2-4.Peer-Reviewed Original ResearchConceptsIntra-abdominal fibrosisIP FUDRCombination of 5-fluorouracilStage III colon adenocarcinomaIsolated liver metastasesSystemic 5-fluorouracilIntra-abdominal recurrenceCarcinoembryonic antigen levelMetastatic colon carcinomaIII colon adenocarcinomaIntra-abdominal massAdjuvant 5-fluorouracilMinimally toxic treatmentLeucovorin therapyIntraperitoneal therapyIP chemotherapyLiver metastasesRecurrent malignancyOvarian carcinomaRetroperitoneal fibrosisAntigen levelsHepatic lobectomyIntra-abdominalIP administrationChemotherapeutic agents
1998
Stage I Rectal Cancer: Identification of High-Risk Patients
Blumberg D, Paty P, Picon A, Guillem J, Klimstra D, Minsky B, Quan S, Cohen A. Stage I Rectal Cancer: Identification of High-Risk Patients. Journal Of The American College Of Surgeons 1998, 186: 574-580. PMID: 9583699, DOI: 10.1016/s1072-7515(98)00018-0.Peer-Reviewed Original ResearchMeSH KeywordsAbdomenActuarial AnalysisAdultAge FactorsAgedAged, 80 and overAnal CanalAnalysis of VarianceBlood VesselsCarcinoembryonic AntigenCombined Modality TherapyDatabases as TopicFemaleFollow-Up StudiesHumansLinear ModelsLymph NodesMaleMiddle AgedMultivariate AnalysisNeoplasm InvasivenessNeoplasm Recurrence, LocalNeoplasm StagingPatient SelectionPerineumPrognosisProportional Hazards ModelsProspective StudiesRectal NeoplasmsRisk FactorsSex FactorsSurvival RateTreatment OutcomeUlcerConceptsTumor-related mortalityBlood vessel invasionStage I rectal cancerPoorly differentiated tumorsHigh-risk patientsSurgical resectionPrognostic factorsMale genderIndependent predictorsVessel invasionIntratumoral blood vessel invasionIntratumoral lymphatic vessel invasionPreoperative carcinoembryonic antigen levelPresence of tumor ulcerationIndependent predictor of recurrenceIdentification of high-risk patientsMethod of Kaplan-MeierAdequate surgical resectionAbdominal perineal resectionPredictor of tumor-related mortalityRadical surgical resectionPredictors of recurrencePrimary rectal cancerCarcinoembryonic antigen levelLow anterior resection
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply